Category Archives: Renu

Featured Stories

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Toxic Nano-Particles from Failing Metal-on-Metal Hip Replacements May Pose Long-Term Health Risks

According to a new study, failing metal-on-metal hip implants generate toxic nano-particles that release Cobalt 2+ ions, which not only cause inflammation in surrounding tissue, but have the potential to cause long-term damage to the genetic material of cells. According to a report published by Medicalxpress.com, this “genotoxicity” could ...

Read More

FDA Panel Takes up Metal-on-Metal Hip Implant Safety Today

The Food and Drug Administration (FDA) is convening a meeting starting today to help decide the future of metal-on-metal hip implants following high-profile recalls and mounting questions about their overall safety.

Read More

Actos Whistleblower Lawsuit Questions Avandia Researcher's Financial Ties to Takeda

A prominent researcher has been implicated in an alleged cover-up of Actos side effects, according to a report from TheHeart.org. An Actos whistleblower lawsuit unsealed earlier this year has alleged financial connections between the Cleveland Clinic’s Dr Steven Nissen and the maker of Actos “should be considered when analyzing Actos’s ...

Read More

Study Finds Plavix May Only Benefit Smokers

An emerging study finds that blood thinner Plavix may only benefit smokers. Plavix (clopidogrel) is prescribed for the prevention of blood clots and heart attacks, and has been linked to serious side effects, including the heart attacks and strokes it is supposed to prevent, gastrointestinal and cerebral bleeding, bleeding ulcers, ...

Read More

Actos, Avandia May Up Risk for Diabetic Macular Edema

A newly published study is raising concerns that patients who take Actos or Avandia may face an increased risk of developing diabetic macular edema, an eye disorder that can result in vision loss. The study, published in the Archives of Internal Medicine, found that type 2 diabetics who use thiazolidinediones, ...

Read More

Smith & Nephew Says Metal-on-Metal Hip Replacement Controversy Slowing Sales of Birmingham Hip Resurfacing System

Medical device maker Smith & Nephew has reported a drop in sales of its metal-on-metal hip implant devices. According to the company, hip implant sales were down 2 percent during the first quarter of 2012, largely because its Birmingham Hip Resurfacing System suffered from an association with other metal-on-metal hip ...

Read More

Failing DePuy ASR Hip Implants Sending Hundreds of Australians Back to the OR

Roughly 1,000 people in Australia have had to undergo revision surgeries because of failed DePuy ASR hip implants. According to TheAge.com, DePuy Orthopaedics has heard from more than 4,000 people in Australia and New Zealand seeking help with the recalled metal-on-metal hip replacement devices.

Read More

Canadian Warning Issued for Actos Bladder Cancer Side Effect Risk

Health Canada has become the most recent national drug regulator to issue a warning about Actos and bladder cancer. Last month, the agency warned that interim results from a 10-year-study indicated that patients taking Actos for more than a year faced an increased risk of bladder cancer. Health Canada also ...

Read More

U.K. Regulators Issue Additional Guidance for Metal-on-Metal Hip Implant Recipients

Regulators in the U.K. are once again issuing advice to doctors and other healthcare professionals involved in the follow-up of patients with metal-on-metal hip replacement devices. In an alert issued by the Medicines and Healthcare products Regulatory Agency (MHRA), guidance is provided for four groups of metal-on-metal hip implant ...

Read More

Bausch & Lomb Renu with MoistureLoc Tests Faulty, New Study Says

< "http://www.yourlawyer.com/topics/overview/renu_contact_solution">Renu with MoistureLoc, the Bausch & Lomb contact lens solution that was responsible for a massive outbreak of Fusarium Keratitis in 2006, was never adequately tested to insure that it was resistant to microbial contamination.   According to a new … Continue reading

Posted in Legal News, Pharmaceuticals, Renu |

Bausch & Lomb CEO Steps Down, 2 Years after Renu with MoistureLoc Recall

The Bausch & Lomb CEO who oversaw the < "http://www.yourlawyer.com/topics/overview/renu_contact_solution">Renu with MoistureLoc recall debacle has stepped down.  Last year, under Ronald Zarella, who served as Bausch & Lomb CEO since 2001, the company was sold to private equity firm Warburg … Continue reading

Posted in Legal News, Pharmaceuticals, Renu |

Bausch & Lomb, Still Reeling from ReNu with MoistureLoc Recall, Announces UK Job Cuts

Bausch & Lomb, the maker of recalled < "http://www.yourlawyer.com/topics/overview/renu_contact_solution">ReNu with MoistureLoc Contact Lens Solution, announced that it would be eliminating 250 jobs at one of its plants in the United Kingdom. The job cuts are just the latest bit of … Continue reading

Posted in Legal News, Pharmaceuticals, Renu |

Bausch & Lomb Goes to Court to Force Insurers to Pay for Renu with MoistureLoc Lawsuits

Bausch & Lomb, maker of the recalled < "http://www.yourlawyer.com/topics/overview/renu_contact_solution">Renu with MoistureLoc contact lens solution, is trying to force several insurance companies to help it pay for more than 1,000 lawsuits filed against the company over the tainted product.  That insurance … Continue reading

Posted in Legal News, Pharmaceuticals, Renu |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.